[{"abstract": "Several plaintiffs\u2019 lawyers have asked that some of their clients be allowed to reject the $4.85 billion Vioxx settlement as others accept it.", "web_url": "https://www.nytimes.com/2007/12/21/business/21vioxx.html", "snippet": "Several plaintiffs\u2019 lawyers have asked that some of their clients be allowed to reject the $4.85 billion Vioxx settlement as others accept it.", "lead_paragraph": "Several plaintiffs\u2019 lawyers have asked the federal judge overseeing the $4.85 billion Vioxx settlement to give them the freedom to keep some of their clients outside the settlement while allowing other clients to accept it.", "print_section": "C", "print_page": "4", "source": "The New York Times", "multimedia": [], "headline": {"main": "Some Lawyers Seek Changes in Vioxx Settlement", "kicker": null, "content_kicker": null, "print_headline": "Lawyers Seek to Alter Settlement Over Vioxx", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Suits and Litigation", "rank": 1, "major": "N"}, {"name": "subject", "value": "Vioxx (Drug)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 3, "major": "N"}], "pub_date": "2007-12-21T05:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Alex Berenson", "person": [{"firstname": "Alex", "middlename": null, "lastname": "Berenson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/1d7253dd-4830-5f9f-bad0-516194a61e7f", "word_count": 669, "uri": "nyt://article/1d7253dd-4830-5f9f-bad0-516194a61e7f"}, {"abstract": "New evidence shows that drug makers Merck and Schering-Plough never published several studies that raised questions about a cholesterol drug\u2019s risks to the liver.", "web_url": "https://www.nytimes.com/2007/12/21/business/21drug.html", "snippet": "New evidence shows that drug makers Merck and Schering-Plough never published several studies that raised questions about a cholesterol drug\u2019s risks to the liver.", "lead_paragraph": "New evidence shows that the drug makers Merck and Schering-Plough have conducted several studies of their popular cholesterol medicine Zetia that raise questions about its risks to the liver, but the companies have never published those results.", "print_section": "C", "print_page": "1", "source": "The New York Times", "multimedia": [], "headline": {"main": "Data About Zetia Risks Was Not Fully Revealed", "kicker": null, "content_kicker": null, "print_headline": "Data About Zetia Risks Was Not Fully Revealed", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Schering Plough Corp", "rank": 1, "major": "N"}, {"name": "subject", "value": "Tests and Testing", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 3, "major": "N"}, {"name": "subject", "value": "Cholesterol", "rank": 4, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 5, "major": "N"}, {"name": "subject", "value": "Zetia (Drug)", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 7, "major": "N"}], "pub_date": "2007-12-21T05:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Alex Berenson", "person": [{"firstname": "Alex", "middlename": null, "lastname": "Berenson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/e7b4a4c0-a768-5677-bc51-a8500034cb40", "word_count": 1634, "uri": "nyt://article/e7b4a4c0-a768-5677-bc51-a8500034cb40"}]